Skip to content

Form 4 filed by Duncan Jason

Duncan Jason filed this Form 4 on enGene Therapeutics Inc. with 1 transaction row and 0 holding rows, accepted by EDGAR 2026-11-13 21:54:00 UTC.

Accession
0001552781-26-000553
Filed
2026-11-13
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

Issuer and reporting owners

Issuer: enGene Therapeutics Inc. (CIK 1980845)

Rows

SecurityDateCodeSharesPriceOwned afterOwnership
Stock Option (Right to Buy) derivative2026-11-13A granted+500,000$0500,000D